Home> Products> dizziness headache constipation confusion

{ "products": [ { "_id": "6990397c160585bfd7038bed", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Baclofen Sustained Release 30 mg", "description": "BACLOFINE SR 30: Comprehensive Product Guide\nProduct Overview\nBACLOFINE SR 30 is an advanced pharmaceutical formulation containing Baclofen 30 mg in a sustained-release delivery system. This prescription medication represents a significant advancement in the management of muscle spasticity and related neuromuscular conditions. The sustained-release technology ensures consistent therapeutic effects throughout the day, providing patients with improved symptom control and enhanced quality of life.\nBaclofen, the active pharmaceutical ingredient in BACLOFINE SR 30, belongs to a class of medications known as skeletal muscle relaxants and antispasmodic agents. The SR (Sustained Release) formulation is specifically engineered to release the medication gradually over an extended period, maintaining steady blood levels and reducing the frequency of dosing compared to conventional immediate-release formulations.\nMechanism of Action and Therapeutic Use\nBACLOFINE SR 30 works by acting on the central nervous system, specifically targeting GABA-B receptors in the spinal cord and brain. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the nervous system. By stimulating these receptors, Baclofen reduces the excessive nerve signals that cause muscles to contract involuntarily, thereby alleviating spasticity and associated discomfort.\nThe sustained-release technology incorporated in BACLOFINE SR 30 utilizes advanced polymer-based matrices that control the rate at which the active ingredient is released into the bloodstream. This innovative approach ensures that patients receive consistent therapeutic coverage for up to 12-24 hours from a single dose, eliminating the peaks and troughs associated with immediate-release formulations.\nPrimary Indications\nBACLOFINE SR 30 is primarily prescribed for managing muscle spasticity associated with various neurological conditions including multiple sclerosis, spinal cord injuries, cerebral palsy, stroke, brain injuries, and other conditions affecting the central nervous system. The medication is particularly beneficial for patients experiencing painful muscle spasms, stiffness, and involuntary muscle contractions that interfere with daily activities, mobility, and rehabilitation efforts.\nKey Benefits of BACLOFINE SR 30\nExtended Duration of Action\nThe most significant advantage of BACLOFINE SR 30 is its sustained-release formulation, which provides prolonged therapeutic effects. Patients typically require only one or two doses per day, compared to three or four doses with conventional formulations. This extended duration improves medication adherence and provides more consistent symptom control throughout the day and night.\nImproved Symptom Management\nBy maintaining steady blood levels of Baclofen, BACLOFINE SR 30 delivers superior control of muscle spasticity with fewer fluctuations in symptom relief. Patients experience reduced muscle stiffness, decreased frequency and severity of muscle spasms, improved range of motion, and enhanced ability to participate in physical therapy and rehabilitation programs.\nEnhanced Quality of Life\nThe consistent therapeutic effects of BACLOFINE SR 30 translate into meaningful improvements in daily functioning. Patients often report better sleep quality due to reduced nighttime spasms, improved mobility and independence in performing daily activities, reduced pain and discomfort associated with muscle spasticity, and greater participation in social and recreational activities.\nReduced Dosing Frequency\nThe sustained-release technology means fewer doses throughout the day, which simplifies medication regimens and improves compliance, particularly for patients managing multiple medications. This convenience factor is especially valuable for individuals with cognitive impairments or those who require caregiver assistance with medication administration.\nSmoother Therapeutic Response\nUnlike immediate-release formulations that can cause pronounced peaks in drug levels, BACLOFINE SR 30 provides a more gradual and sustained therapeutic effect. This results in reduced risk of dose-related side effects, more stable muscle relaxation throughout the dosing interval, and minimized breakthrough spasticity between doses.\nPotential Side Effects and Considerations\nWhile BACLOFINE SR 30 is generally well-tolerated, patients should be aware of potential side effects. It's important to note that not everyone experiences these effects, and many side effects diminish as the body adjusts to the medication.\nCommon Side Effects\nThe most frequently reported side effects include drowsiness and sedation, which typically occur during initial therapy or dose adjustments. Patients may also experience dizziness, fatigue, weakness, headache, nausea, and constipation. These effects are usually mild to moderate and often resolve within the first few weeks of treatment.\nCentral Nervous System Effects\nSome patients may experience confusion, particularly elderly individuals, difficulty concentrating, insomnia or sleep disturbances, and mood changes. These effects should be monitored and reported to healthcare providers if they persist or worsen.\nCardiovascular and Other Effects\nOccasional side effects may include hypotension (low blood pressure), urinary frequency or retention, dry mouth, and muscle weakness beyond the intended therapeutic effect.\nSerious Considerations\nPatients should seek immediate medical attention if they experience severe allergic reactions, hallucinations or severe confusion, difficulty breathing, severe muscle weakness affecting breathing or swallowing, or signs of overdose including extreme drowsiness, respiratory depression, or seizures.\nImportant Warnings\nBACLOFINE SR 30 should never be discontinued abruptly without medical supervision, as sudden withdrawal can lead to serious complications including seizures, hallucinations, increased spasticity, and other potentially life-threatening symptoms. Dose reduction must be gradual and carefully supervised by a healthcare provider.\nThe medication may cause drowsiness and impair mental alertness, so patients should avoid driving, operating machinery, or engaging in activities requiring full alertness until they understand how the medication affects them. Alcohol and other central nervous system depressants should be avoided or used with extreme caution, as they can potentiate the sedative effects of Baclofen.\nDosage and Administration Guidelines\nBACLOFINE SR 30 should be taken exactly as prescribed by a healthcare provider. The tablets should be swallowed whole and not crushed, chewed, or broken, as this would compromise the sustained-release mechanism and potentially lead to dose dumping. The medication can be taken with or without food, though taking it with food may help reduce gastrointestinal side effects.\nDosage is highly individualized based on the patient's condition, response to treatment, and tolerance. Healthcare providers typically initiate therapy at lower doses and gradually titrate upward to achieve optimal therapeutic effects while minimizing side effects.\nConclusion\nBACLOFINE SR 30 represents a sophisticated therapeutic option for individuals struggling with muscle spasticity and related neuromuscular conditions. The sustained-release formulation offers distinct advantages over conventional immediate-release preparations, including extended duration of action, improved symptom control, reduced dosing frequency, and enhanced patient convenience and compliance.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2306, "imageuri": "https://productimages.withfloats.com/actual/6990397eb2070251db7032d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6990397eb2070251db7032d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-14T08:59:40.632Z", "updatedon": "2026-04-28T12:02:50.6Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/baclofen-sustained-release-30-mg/2306", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BACLOFINE SR 30", "category": "NEUROLOGYRANGE", "tags": [ "baclofen sr 30 mg tablet uses", "what is baclofen sr 30 prescribed for", "baclofen sr 30 mg dosage guide", "baclofen sr 30 mg for back pain", "baclofen sr 30 mg vs regular baclofen", "baclofen sr 30 mg for spinal cord injury", "baclofen sr 30 mg side effects in adults", "is baclofen sr 30 mg addictive", "buy baclofen sr 30 mg online", "baclofen sr 30 mg manufacturer", "baclofen sr 30 mg prescription required", "baclofen sr 30 mg vs baclofen 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69901185ae41895d8787c4d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Trazodone Hydrochloride", "description": "TORRANE 100 is a pharmaceutical formulation containing Trazodone Hydrochloride 100 mg as its active ingredient. This prescription medication belongs to the class of serotonin antagonist and reuptake inhibitors (SARIs), primarily designed to address major depressive disorder and associated sleep disturbances. TORRANE 100 represents a therapeutic solution that combines antidepressant properties with sedative effects, making it a versatile option for patients struggling with depression, particularly when accompanied by insomnia or anxiety symptoms.\nThe formulation comes in tablet form, designed for oral administration, and works by modulating serotonin levels in the brain. Unlike many traditional antidepressants, TORRANE 100 offers a unique mechanism of action that sets it apart in the treatment landscape, providing relief not only from depressive symptoms but also addressing sleep-related issues that often accompany mental health conditions.\nHow TORRANE 100 Works\nTORRANE 100 operates through a dual mechanism that influences brain chemistry. The active ingredient, Trazodone Hydrochloride, primarily inhibits the reuptake of serotonin—a neurotransmitter crucial for mood regulation—while simultaneously blocking certain serotonin receptors. This balanced approach helps restore emotional equilibrium and promotes a sense of well-being.\nThe medication's sedative properties stem from its antihistamine effects and alpha-adrenergic blocking activity, which contribute to its effectiveness in treating insomnia. When taken as prescribed, TORRANE 100 typically begins working within one to two weeks for depressive symptoms, though sleep improvements may be noticed sooner, often within the first few days of treatment.\nPrimary Uses and Applications\nTORRANE 100 is indicated for several therapeutic purposes:\nMajor Depressive Disorder: The primary indication for TORRANE 100 is the treatment of depression. Patients experiencing persistent sadness, loss of interest in daily activities, changes in appetite, or feelings of worthlessness may benefit from this medication under proper medical supervision.\nInsomnia Associated with Depression: One of the distinguishing features of TORRANE 100 is its effectiveness in treating sleep disturbances linked to depression. The medication helps patients fall asleep faster and maintain sleep throughout the night without causing the same dependency concerns associated with traditional sleeping pills.\nAnxiety Disorders: Healthcare providers sometimes prescribe TORRANE 100 off-label for anxiety disorders, as the medication's calming properties can help reduce excessive worry and tension.\nChronic Pain Management: In some cases, medical professionals utilize TORRANE 100 as part of a comprehensive pain management strategy, particularly for conditions involving neuropathic pain.\nKey Benefits of TORRANE 100\nThe therapeutic advantages of TORRANE 100 extend beyond simple symptom management:\nDual Action Formula: Unlike medications that target only depression or only sleep, TORRANE 100 addresses both concerns simultaneously, reducing the need for multiple prescriptions and simplifying treatment regimens.\nLower Addiction Potential: Compared to benzodiazepines and other sedative-hypnotics, TORRANE 100 carries a significantly lower risk of dependency, making it a safer long-term option for patients requiring ongoing sleep support.\nImproved Sleep Architecture: The medication promotes natural sleep patterns without severely disrupting REM sleep, which is essential for cognitive function and emotional processing.\nFewer Sexual Side Effects: Unlike many selective serotonin reuptake inhibitors (SSRIs), TORRANE 100 typically causes fewer sexual dysfunction issues, which can improve treatment adherence and quality of life.\nMood Stabilization: Patients often experience gradual improvement in overall mood, reduced irritability, and enhanced emotional resilience as treatment progresses.\nAnxiety Reduction: The anxiolytic properties help diminish racing thoughts and physical tension that often accompany depressive episodes.\nEnhanced Daily Functioning: By improving both mood and sleep quality, TORRANE 100 helps patients regain energy, concentration, and motivation to engage in daily activities and maintain relationships.\nPotential Side Effects\nWhile TORRANE 100 is generally well-tolerated, patients should be aware of possible adverse reactions:\nCommon Side Effects: Drowsiness and dizziness are the most frequently reported effects, particularly when initiating treatment or adjusting dosage. Dry mouth, blurred vision, constipation, and headaches may also occur but typically diminish as the body adjusts to the medication.\nOrthostatic Hypotension: Some patients experience a drop in blood pressure upon standing, leading to lightheadedness. Rising slowly from sitting or lying positions can help minimize this effect.\nGastrointestinal Disturbances: Nausea, vomiting, or changes in appetite may occur, though taking the medication with food often reduces these symptoms.\nWeight Changes: Some individuals may experience weight gain or loss during treatment.\nSerious but Rare Side Effects: Though uncommon, patients should seek immediate medical attention if experiencing priapism (prolonged painful erection), irregular heartbeat, severe dizziness, fainting, or signs of serotonin syndrome (confusion, rapid heartbeat, severe muscle stiffness).\nCardiac Considerations: TORRANE 100 may cause changes in heart rhythm, particularly in patients with pre-existing cardiac conditions.\nWithdrawal Symptoms: Abrupt discontinuation may lead to withdrawal effects; therefore, dosage should be tapered gradually under medical supervision.\nImportant Safety Considerations\nPatients should inform their healthcare provider about all medications, supplements, and herbal products they're taking, as TORRANE 100 can interact with numerous substances. Alcohol should be avoided, as it can intensify sedative effects. The medication may impair judgment and coordination, so caution is advised when driving or operating machinery until individual response is established.\nPregnant women, nursing mothers, and individuals with certain medical conditions should discuss the risks and benefits with their healthcare provider before starting TORRANE 100. Regular monitoring and follow-up appointments are essential to ensure optimal therapeutic outcomes and promptly address any concerns.\nConclusion\nTORRANE 100 represents a valuable therapeutic option for individuals battling depression, particularly when complicated by sleep disturbances. Its unique pharmacological profile offers comprehensive relief by addressing multiple symptoms simultaneously, potentially improving treatment adherence and quality of life. The medication's relatively favorable side effect profile, combined with lower addiction potential compared to traditional sleep aids, makes it an attractive choice for long-term management.", "price": 105.0, "discountamount": 32.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2304, "imageuri": "https://productimages.withfloats.com/actual/69901186e8395ed6920a6b9a.png", "tileimageuri": "https://productimages.withfloats.com/tile/69901186e8395ed6920a6b9a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-14T06:09:09.093Z", "updatedon": "2026-03-13T07:59:53.859Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trazodone-hydrochloride/2304", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TORRANE 100", "category": "NEUROLOGY RANGE", "tags": [ "trazodone hydrochloride 100 mg tablet uses", "what is trazodone hydrochloride 100 mg used for", "trazodone hydrochloride 100 mg for sleep dosage", "trazodone hydrochloride 100 mg side effects in adults", "how long does trazodone hydrochloride 100 mg last", "trazodone hydrochloride 100 mg for anxiety reviews", "trazodone hydrochloride 100 mg weight gain risk", "trazodone hydrochloride 100 mg for insomnia effectiveness", "can I take trazodone hydrochloride 100 mg every night", "trazodone hydrochloride 100 mg liver side effects", "buy trazodone hydrochloride 100 mg online prescription", "trazodone hydrochloride 100 mg generic brand name", "trazodone hydrochloride 100 mg vs melatonin for sleep", "trazodone hydrochloride 100 mg vs mirtazapine" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-04-18T09:21:49.885Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin.", "Pregabalin Epalrestat and Methylcobalamin Tablets", "epalrestat and methylcobalamin tablets uses", "epalrestat and methylcobalamin tablets in hindi", "pregabalin epalrestat and methylcobalamin tablets price jaipur", "pregabalin epalrestat and methylcobalamin tablets price india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66642f1266170d1ff8cb648d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Memantine 10mg", "description": "MENTATIME 10 \nMementine (10mg)\nMentatime 10 contains Mementine (10mg), which is a medication primarily used to treat Alzheimer's disease and other forms of dementia. Mementine belongs to a class of drugs called NMDA receptor antagonists, which work by regulating the activity of glutamate, a neurotransmitter involved in learning and memory.\n\nThis medication helps improve cognitive function, including memory, attention, reasoning, and language. It may also help with behavioral symptoms associated with dementia, such as agitation and aggression.\n\nMentatime 10 is often prescribed as part of a comprehensive treatment plan for Alzheimer's disease and may be used alone or in combination with other medications. It is important to follow the prescribed dosage and instructions provided by your healthcare provider.\n\nCommon side effects of Mementine include dizziness, headache, confusion, and constipation. Serious side effects are rare but may include hallucinations, seizures, and changes in heart rhythm. If you experience any concerning symptoms while taking Mentatime 10, contact your healthcare provider immediately.\n\nIt is important to note that Mentatime 10 is not a cure for Alzheimer's disease or dementia but can help manage symptoms and improve quality of life for some individuals. It is essential to continue regular check-ups with your healthcare provider to monitor the effectiveness and safety of this medication.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mentatime-10-133777\n\n\n\n\n\n\n", "price": 172.0, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "life", "cure", "part", "ORDER", "class", "Email", "drugs", "safety", "memory", "dosage", "product", "quality", "changes", "disease", "seizures", "WhatsApp", "headache", "learning", "language", "activity", "dementia", "Alzheimer", "attention", "reasoning", "confusion", "agitation", "glutamate", "MENTATIME", "Mementine", "dizziness", "aggression", "individuals", "combination", "information", "other forms", "heart rhythm", "instructions", "sterisonline", "sterispharma", "constipation", "effectiveness", "hallucinations", "neurotransmitter", "regular check-ups", "other medications", "cognitive function", "healthcare provider", "behavioral symptoms", "Common side effects", "Serious side effects", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1572, "imageuri": "https://productimages.withfloats.com/actual/66642f152763378392d53dad.png", "tileimageuri": "https://productimages.withfloats.com/tile/66642f152763378392d53dad.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:14:42.722Z", "updatedon": "2026-03-14T10:58:37.622Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//memantine-10mg/1572", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MENTATIME 10 ", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a392f71ac59196530375cb2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "cabergoline tablets 0.25 mg", "description": "Cabergoline Tablets 0.25 mg are widely prescribed for the treatment of conditions associated with elevated prolactin levels in the body. This medication belongs to a class of drugs known as dopamine agonists and is highly effective in managing hormonal imbalances that can affect fertility, menstrual health, and pituitary gland function.\n\nPatients searching for cabergoline tablets 0.25 mg, cabergoline 0.25 mg uses, cabergoline tablet price, cabergoline side effects, and cabergoline dosage often want detailed information before making a purchase decision. This comprehensive guide explains everything you need to know about Cabergoline Tablets 0.25 mg, including benefits, mechanism of action, dosage recommendations, precautions, and frequently asked questions.\n\nWhat Are Cabergoline Tablets 0.25 mg?\n\nCabergoline Tablets 0.25 mg contain cabergoline as the active pharmaceutical ingredient. The medicine is primarily used to lower abnormally high prolactin levels in the blood, a condition known as hyperprolactinemia.\n\nHigh prolactin levels can lead to:\n\nIrregular menstrual cycles\nInfertility\nUnwanted breast milk production\nReduced libido\nErectile dysfunction in men\nPituitary gland disorders\n\nCabergoline works by restoring hormonal balance and helping patients regain normal reproductive and endocrine function.\n\nHow Does Cabergoline 0.25 mg Work?\n\nCabergoline acts as a dopamine receptor agonist. Dopamine is a natural chemical in the brain that helps regulate prolactin secretion.\n\nMechanism of Action\n\nThe medication stimulates dopamine D2 receptors located in the pituitary gland. This action suppresses prolactin production and release.\n\nAs prolactin levels decrease:\n\nMenstrual cycles become more regular.\nFertility may improve.\nSymptoms of prolactin-producing tumors may reduce.\nBreast milk production caused by elevated prolactin decreases.\nHormonal balance improves.\n\nThe long duration of action of cabergoline allows for less frequent dosing compared to some alternative therapies.\n\nWhy Is Cabergoline Tablets 0.25 mg Important?\n\nMaintaining normal prolactin levels is crucial for reproductive health and hormonal stability.\n\nUntreated hyperprolactinemia may lead to:\n\nInfertility\nMenstrual disorders\nOsteoporosis\nSexual dysfunction\nPituitary tumor progression\n\nCabergoline Tablets 0.25 mg help address the root cause of these symptoms and improve overall quality of life.\n\nKey Benefits of Cabergoline Tablets 0.25 mg\nEffective Prolactin Control\n\nCabergoline significantly lowers elevated prolactin levels and helps restore hormonal balance.\n\nImproves Fertility\n\nWomen struggling with infertility due to elevated prolactin levels may experience improved reproductive function.\n\nRestores Menstrual Regularity\n\nThe medication helps normalize menstrual cycles in women with hormonal imbalances.\n\nReduces Galactorrhea\n\nCabergoline effectively decreases inappropriate breast milk production.\n\nSupports Pituitary Health\n\nIt helps manage prolactin-secreting pituitary tumors (prolactinomas).\n\nConvenient Dosing Schedule\n\nDue to its long half-life, Cabergoline often requires fewer doses per week than many alternative medications.\n\nIndications of Cabergoline Tablets 0.25 mg\n\nDoctors commonly prescribe Cabergoline Tablets 0.25 mg for:\n\nHyperprolactinemia\nProlactin-secreting pituitary adenomas (prolactinomas)\nMenstrual irregularities caused by elevated prolactin\nFemale infertility associated with high prolactin\nGalactorrhea\nHormonal imbalance disorders\nCertain endocrine conditions requiring prolactin suppression\nEfficacy and Clinical Evidence\n\nClinical studies have consistently demonstrated the effectiveness of cabergoline in reducing prolactin levels.\n\nResearch has shown that Cabergoline:\n\nProduces significant prolactin reduction\nRestores ovulation in many women\nImproves fertility outcomes\nReduces tumor size in prolactinoma patients\nOffers long-term symptom control\n\nIts favorable efficacy profile makes it one of the most commonly prescribed dopamine agonists for hyperprolactinemia management.\n\nDosage Guidelines for Cabergoline Tablets 0.25 mg\n\nAlways follow your healthcare provider's instructions.\n\nTypical Dosage\n\nThe dosage depends on:\n\nSeverity of the condition\nProlactin levels\nPatient response\nMedical history\n\nTreatment usually begins with a low dose and may be adjusted gradually based on clinical response.\n\nAdministration Tips\nTake the tablet exactly as prescribed.\nSwallow with water.\nCan be taken with food to minimize stomach discomfort.\nMaintain a consistent dosing schedule.\nMissed Dose\n\nIf you miss a dose:\n\nTake it as soon as remembered.\nSkip if the next scheduled dose is near.\nNever double the dose.\nSide Effects of Cabergoline Tablets 0.25 mg\n\nLike all medicines, Cabergoline may cause side effects.\n\nCommon Side Effects\nNausea\nHeadache\nDizziness\nFatigue\nConstipation\nAbdominal discomfort\nLow blood pressure\nSleepiness\n\nMost side effects are mild and improve as the body adjusts to treatment.\n\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nChest pain\nShortness of breath\nSevere dizziness\nPersistent swelling\nFainting episodes\nSevere allergic reactions\nSignificant mood changes\nPrecautions and Warnings\n\nBefore using Cabergoline Tablets 0.25 mg, inform your doctor if you have:\n\nHeart Disease\n\nPatients with cardiovascular conditions require careful monitoring.\n\nLiver Disorders\n\nDose adjustments may be necessary in certain cases.\n\nPregnancy\n\nUse only when specifically prescribed by a healthcare provider.\n\nBreastfeeding\n\nConsult your physician before taking Cabergoline during breastfeeding.\n\nMental Health Conditions\n\nPatients with psychiatric disorders should discuss their medical history with their doctor.\n\nLow Blood Pressure\n\nCabergoline may further reduce blood pressure in susceptible individuals.\n\nDrug Interactions\n\nCabergoline may interact with:\n\nAntipsychotic medications\nBlood pressure medications\nDopamine antagonists\nCertain antibiotics\nOther hormonal therapies\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nCabergoline Tablets 0.25 mg Price\n\nPatients frequently search for information regarding cabergoline tablet price before purchasing treatment.\n\nThe cost may vary depending on:\n\nBrand\nPharmacy location\nPack size\nAvailability\nPrescription requirements\n\nFor accurate pricing and availability, consult your local pharmacy or authorized pharmaceutical distributor.\n\nStorage Instructions\nStore below recommended room temperature.\nKeep away from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose Steris Healthcare Products?\n\nSteris Healthcare Pvt. Ltd. is committed to delivering high-quality pharmaceutical products manufactured under strict quality standards.\n\nAdvantages Include:\nWHO-GMP certified manufacturing facilities\nStringent quality control\nReliable pharmaceutical formulations\nPatient-focused healthcare solutions\nConsistent product quality\n\nHealthcare professionals trust Steris Healthcare for dependable pharmaceutical products that meet industry standards.\n\nConclusion\n\nCabergoline Tablets 0.25 mg are an effective treatment option for managing elevated prolactin levels, prolactinomas, hormonal imbalance, infertility, and related endocrine disorders. By acting directly on dopamine receptors, the medication helps restore normal prolactin levels and improves reproductive health outcomes.\n\nPatients seeking a proven therapy for hyperprolactinemia often benefit from the convenience, efficacy, and long-lasting action of Cabergoline. However, treatment should always be undertaken under medical supervision with regular monitoring and follow-up.\n\nFrequently Asked Questions (FAQs)\nWhat is Cabergoline Tablets 0.25 mg used for?\n\nCabergoline Tablets 0.25 mg are primarily used to treat hyperprolactinemia, prolactinomas, infertility associated with high prolactin levels, and hormonal disorders.\n\nHow does Cabergoline work?\n\nCabergoline stimulates dopamine receptors in the pituitary gland, reducing prolactin production and restoring hormonal balance.\n\nCan Cabergoline improve fertility?\n\nYes. In many women, lowering elevated prolactin levels can help restore ovulation and improve fertility.\n\nHow long does Cabergoline take to work?\n\nMany patients experience a reduction in prolactin levels within a few weeks, although results vary depending on the condition being treated.\n\nWhat are the common side effects of Cabergoline?\n\nCommon side effects include nausea, headache, dizziness, constipation, fatigue, and abdominal discomfort.\n\nCan Cabergoline be taken with food?\n\nYes. Taking Cabergoline with food may help reduce stomach-related side effects.\n\nIs Cabergoline safe for long-term use?\n\nWhen prescribed and monitored by a healthcare professional, Cabergoline can be used safely for long-term treatment in appropriate patients.\n\nCan men take Cabergoline Tablets 0.25 mg?\n\nYes. Men with elevated prolactin levels or prolactin-related disorders may benefit from Cabergoline therapy.\n\nIs a prescription required for Cabergoline?\n\nYes. Cabergoline Tablets 0.25 mg are prescription-only medications and should be used under medical supervision.\n\nHow should Cabergoline tablets be stored?\n\nStore the medication in a cool, dry place away from moisture, sunlight, and the reach of children.\nProduct Information Template\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2457, "imageuri": "https://productimages.withfloats.com/actual/6a392f73cf03f058fecf81dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a392f73cf03f058fecf81dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-22T12:49:53.333Z", "updatedon": "2026-06-22T12:49:53.333Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cabergoline-tablets-0-25-mg/2457", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CABERGLOW 0.25", "category": "GYANECOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69902dc8911df6d4b0db4385", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Trazodone Hydrochloride 50 mg", "description": "TORRANE 50 is a pharmaceutical formulation containing Trazodone Hydrochloride 50 mg as its active ingredient. This medication belongs to the class of serotonin antagonist and reuptake inhibitors (SARIs), primarily prescribed for the management of major depressive disorder and associated sleep disturbances. TORRANE 50 represents a trusted therapeutic option that has been helping individuals regain emotional balance and improve their quality of life for decades. The medication works by modulating serotonin levels in the brain, offering relief from depression while simultaneously addressing insomnia that often accompanies mood disorders.\nUnderstanding Trazodone Hydrochloride\nTrazodone Hydrochloride is a unique antidepressant that distinguishes itself from other medications in its class through its dual-action mechanism. Unlike traditional selective serotonin reuptake inhibitors (SSRIs), TORRANE 50 not only helps restore serotonin balance but also possesses sedative properties that make it particularly valuable for patients struggling with both depression and sleep difficulties. The 50mg dosage represents a common starting point for treatment, allowing healthcare providers to carefully titrate the dose according to individual patient needs and responses.\nPrimary Uses and Applications\nTORRANE 50 serves multiple therapeutic purposes, making it a versatile option in psychiatric and general medical practice. The primary indication for this medication is major depressive disorder, where it helps alleviate symptoms such as persistent sadness, loss of interest in daily activities, feelings of worthlessness, and difficulty concentrating. Beyond its antidepressant properties, TORRANE 50 has gained significant recognition for its effectiveness in treating insomnia, particularly when sleep disturbances are related to depression or anxiety.\nHealthcare providers may also prescribe TORRANE 50 off-label for various conditions including generalized anxiety disorder, panic disorder, and chronic pain conditions where sleep disturbance is a prominent feature. The medication's ability to improve sleep architecture without the dependency risks associated with traditional benzodiazepines makes it an attractive option for long-term management of sleep-related issues.\nKey Benefits and Therapeutic Advantages\nThe benefits of TORRANE 50 extend far beyond simple symptom management, offering patients a comprehensive approach to mental health wellness. One of the most significant advantages is its dual-action profile, addressing both mood and sleep disturbances simultaneously. This is particularly beneficial because depression and insomnia often exist in a cyclical relationship, where each condition exacerbates the other.\nTORRANE 50 demonstrates a relatively favorable side effect profile compared to some other antidepressants, with lower risks of sexual dysfunction, which is a common concern with many SSRI medications. This makes it an excellent alternative for patients who have experienced these troublesome side effects with other antidepressants. Additionally, the medication is not associated with significant weight gain in most patients, addressing another common concern that can affect medication adherence.\nThe sedative properties of TORRANE 50, while beneficial for sleep, are dose-dependent, allowing physicians to customize treatment strategies. At lower doses, the medication primarily promotes sleep, while higher doses deliver more pronounced antidepressant effects. This flexibility enables healthcare providers to tailor treatment to individual patient needs effectively.\nAnother notable benefit is that TORRANE 50 has a relatively low potential for abuse compared to benzodiazepines and other sleep medications, making it safer for long-term use in appropriate patients. The medication also begins to improve sleep quality relatively quickly, often within the first week of treatment, though the full antidepressant effects may take several weeks to manifest fully.\nPotential Side Effects and Considerations\nLike all medications, TORRANE 50 may cause side effects, though not everyone experiences them. Understanding these potential effects helps patients and healthcare providers work together to optimize treatment outcomes. Common side effects include drowsiness and dizziness, particularly when starting the medication or increasing the dose. These effects are often most pronounced in the first few days of treatment and typically diminish as the body adjusts to the medication.\nSome patients may experience dry mouth, blurred vision, constipation, or headaches. These anticholinergic effects are generally mild and manageable. Nausea and gastrointestinal discomfort can occur, particularly if the medication is taken on an empty stomach. Taking TORRANE 50 with food can help minimize these digestive concerns.\nMore serious but less common side effects include orthostatic hypotension, which is a sudden drop in blood pressure upon standing that can lead to dizziness or fainting. Patients, especially older adults, should be cautioned to rise slowly from sitting or lying positions. In rare cases, TORRANE 50 may cause priapism, a prolonged and painful erection requiring immediate medical attention.\nCardiac considerations include potential changes in heart rhythm, and patients with pre-existing heart conditions should be monitored carefully. Some individuals may experience changes in alertness or cognitive function, which can affect the ability to drive or operate machinery safely, particularly when first starting treatment.\nAs with many antidepressants, there is a theoretical risk of increased suicidal thoughts, particularly in young adults and adolescents during the initial weeks of treatment. Close monitoring during this period is essential, and patients should immediately report any worsening of depression or emergence of suicidal thoughts.\nImportant Safety Information\nPatients should inform their healthcare provider about all medications, supplements, and herbal products they are taking, as TORRANE 50 can interact with numerous substances. Particularly significant interactions occur with monoamine oxidase inhibitors (MAOIs), other antidepressants, blood thinners, and medications affecting the central nervous system. Alcohol should be avoided during treatment as it can intensify sedation and increase the risk of adverse effects.\nTORRANE 50 should not be stopped abruptly without medical supervision, as discontinuation syndrome can occur, causing symptoms such as anxiety, agitation, and sleep disturbances. Healthcare providers will typically recommend gradual dose reduction when discontinuing the medication.\nConclusion\nTORRANE 50 (Trazodone Hydrochloride 50 mg) represents a valuable therapeutic option for individuals struggling with depression and sleep disturbances. Its unique dual-action mechanism, addressing both mood regulation and sleep quality, sets it apart in the landscape of psychiatric medications. The favorable side effect profile, particularly regarding sexual function and weight concerns, combined with its low abuse potential, makes TORRANE 50 an attractive choice for both patients and healthcare providers.", "price": 76.0, "discountamount": 23.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2305, "imageuri": "https://productimages.withfloats.com/actual/69902dca78523277e04db86e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69902dca78523277e04db86e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-14T08:09:44.427Z", "updatedon": "2026-03-13T07:58:53.427Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//trazodone-hydrochloride-50-mg/2305", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TORRANE 50", "category": "NEUROLOGYRANGE", "tags": [ "trazodone hydrochloride 50 mg tablet uses", "what is trazodone hydrochloride 50 mg prescribed for", "trazodone hydrochloride 50 mg for insomnia reviews", "trazodone hydrochloride 50 mg for anxiety dosage", "is trazodone hydrochloride 50 mg enough for sleep", "trazodone hydrochloride 50 mg weight gain", "can you take trazodone hydrochloride 50 mg every night", "trazodone hydrochloride 50 mg withdrawal symptoms", "trazodone hydrochloride 50 mg overdose risk", "buy trazodone hydrochloride 50 mg online prescription", "trazodone hydrochloride 50 mg price without insurance", "trazodone hydrochloride 50 mg manufacturer", "trazodone hydrochloride 50 mg vs mirtazapine" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-04-21T09:38:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride", "esomeprazole and itopride capsules uses in hindi", "esomeprazole and itopride capsules uses", "esomeprazole and itopride brand name", "esomeprazole and itopride hydrochloride", "esomeprazole and itopride capsules", "esomeprazole and itopride uses", "esomeprazole and itopride hydrochloride capsules", "esomeprazole and itopride hydrochloride uses", "esomeprazole and itopride hydrochloride price", "esomeprazole and itopride hydrochloride price in india", "buy online Esomeprazole and Itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6960c83f3056ad8a5a1aecba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinnarizine and Domperidone Tablets ", "description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2271, "imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png", "tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-09T09:19:59.281Z", "updatedon": "2026-03-12T09:24:10.244Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLANARIZINE DOM", "category": "NEUROLOGY RANGE", "tags": [ "cinnarizine and domperidone tablet uses", "what is cinnarizine & domperidone tablet used for", "cinnarizine domperidone combination medicine benefits", "how cinnarizine domperidone tablet works", "cinnarizine domperidone tablet for vertigo treatment", "cinnarizine domperidone tablet for inner ear problem", "cinnarizine domperidone tablet for balance disorder", "cinnarizine domperidone tablet for travel sickness", "cinnarizine domperidone tablet for gastric nausea", "cinnarizine & domperidone tablet price in india", "cinnarizine domperidone tablet brand name", "cinnarizine domperidone tablet manufacturer in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958dbfa1063d98b1e8f2fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benidipine 4mg", "description": "BENIPRIME 4, containing Benidipine 4 mg, offers effective management for high blood pressure and related heart conditions. This calcium channel blocker helps relax blood vessels to improve blood flow and reduce strain on the heart. Patients often find it reliable for daily control of hypertension symptoms.\n\nWhat is BENIPRIME 4?\nBENIPRIME 4 is a branded tablet from Steris Healthcare Pvt Ltd, featuring 4 mg of Benidipine as the active ingredient. Benidipine belongs to the dihydropyridine class of calcium channel blockers, designed specifically for cardiovascular health. Each tablet delivers a precise dose in a user-friendly form, typically packaged in strips of 10 for convenient use. Manufactured under strict quality standards, it targets essential needs in hypertension care, making it a staple in many treatment plans across India.\n​\n\nThis medication stands out due to its triple action on L-type, N-type, and T-type calcium channels, providing broader vascular protection compared to some other blockers. Doctors prescribe it for adults dealing with persistent high blood pressure or chest pain, often starting at this 4 mg strength for balanced efficacy. Unlike generic options, BENIPRIME 4 ensures consistent absorption and formulation tailored for Indian patients, with pricing around Rs 62-89 per strip after discounts.\n​\n\nHow BENIPRIME 4 Works\nBenidipine in BENIPRIME 4 blocks calcium entry into smooth muscle cells of blood vessels and heart muscles. This action causes vasodilation, widening arteries to lower resistance and ease blood flow. By reducing systolic and diastolic pressure, it lightens the heart's workload without drastically slowing the heartbeat.\n​\n\nThe unique blockade of multiple calcium channels also boosts nitric oxide production, offering antioxidant effects and protection against artery hardening. This sustained mechanism provides 24-hour control, ideal for once-daily dosing after breakfast. Over time, it may even reduce urinary protein and triglycerides, supporting kidney and metabolic health in hypertensives.\n​\n\nKey Uses of BENIPRIME 4\nBENIPRIME 4 primarily treats essential hypertension, helping prevent strokes, heart attacks, and kidney damage. It effectively manages angina pectoris by enhancing coronary blood supply, reducing chest pain episodes during activity.\n​\n\nPhysicians also use it for renal parenchymal hypertension, where kidney issues elevate blood pressure. In emergencies like hypertensive crises or subarachnoid hemorrhage, higher doses prove beneficial, though 4mg serves as maintenance. For arrhythmia or anal fissures linked to vascular strain, it offers supportive relief.\n​\n\nLowers high blood pressure in adults, including severe cases with dose adjustments.\n​\n\nEases angina symptoms, improving exercise tolerance and daily life quality.\n​\n\nProtects renal function in proteinuric patients by stabilizing vessels.\n​\n\nDosage and Administration\nTake BENIPRIME 4 as 4 mg once daily, swallowed whole after a meal to minimize stomach upset. Doctors may adjust to 2-8mg based on response, age, or kidney/liver status, never exceeding 8 mg daily without monitoring. Consistency in timing ensures steady levels for optimal pressure control.\n​\n\nMissed doses require prompt intake if remembered soon, but skip if near the next one—avoid doubles. Pair with lifestyle changes like low-salt diets and exercise for best results. Always consult for personalization, especially in elderly or comorbid patients.\n​\n\nKey Benefits\nBENIPRIME 4 excels in long-term blood pressure reduction, with studies showing sustained drops in brachial-ankle pulse wave velocity beyond mere pressure effects. It protects the heart and kidneys through anti-sclerotic and antioxidant actions, lowering cardiovascular event risks.\n​\n\nPatients experience fewer angina attacks, better endurance, and improved quality of life. The once-daily regimen boosts adherence, while vascular selectivity minimizes reflex tachycardia common in other blockers. Clinical data indicate reduced C-reactive protein and aldosterone, curbing inflammation and fibrosis.\n​\n\nBenefit\tDescription\tSupporting Evidence\nBP Control\tReduces systolic/diastolic pressure effectively over 24 hours \n​\tLong-term studies show persistent effects post-treatment \n​\nHeart Protection\tImproves coronary flow, cuts angina frequency \n​\tMyocardial protection via NO stimulation \n​\nRenal Support\tLowers proteinuria, aids kidney hypertension \n​\tAnti-oxidative vascular benefits \n​\nAdherence Ease\tOnce-daily dosing with sustained release \n​\tHigh membrane affinity for lasting action \n​\nAdditional perks include potential triglyceride reduction and osteoblast stimulation for bone health in hypertensives.\n\nPotential Side Effects\nMost users tolerate BENIPRIME 4 well, with mild, transient effects resolving spontaneously. Common issues include headache, dizziness, flushing, ankle swelling, palpitations, fatigue, nausea, and sleepiness.\n​\n\nLess frequent are constipation, abdominal pain, tinnitus, shoulder stiffness, urinary frequency, or elevated liver enzymes. Rare serious reactions involve severe hypotension, rash, itching, or allergic responses—seek immediate care if these arise. Monitor blood pressure during initiation to avoid drops.\n\nHeart-related: Palpitations, chest pressure\n​\n\nNervous system: Dizziness, headache\n\nSkin/Vascular: Flushing, edema.\n\nGI: Nausea, constipation\n​\n\nLiver/kidney patients need caution; inform doctors of history.\n\n\nPrecautions and Interactions\nAvoid in hypotension, severe aortic stenosis, or hypersensitivity to dihydropyridines. Use cautiously in liver/kidney impairment, pregnancy, or breastfeeding—benefits must outweigh risks. Grapefruit juice may amplify effects; limit alcohol.\n​\n\nIt interacts with beta-blockers, digoxin, or CYP3A4 inhibitors like ketoconazole, potentially enhancing hypotension. Regular monitoring of BP, electrolytes, and renal function is advised during therapy. Abrupt stop may rebound pressure; taper under guidance.\n​\nConclusion\nBENIPRIME 4 with Benidipine 4 mg empowers reliable hypertension and angina control through innovative calcium channel action. Balancing potent benefits like organ protection and ease of use against manageable side effects, it fits seamlessly into modern cardiac care. Consult healthcare providers for tailored integration with lifestyle for lasting heart health. ", "price": 89.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2261, "imageuri": "https://productimages.withfloats.com/actual/6958dbfc615a7d157715572f.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6958dbfc615a7d157715572f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T09:06:02.841Z", "updatedon": "2026-03-13T06:54:02.808Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benidipine-4mg/2261", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENIPRIME 4", "category": "CARDIOLOGYRANGE", "tags": [ "benidipine 4mg", "benidipine 4mg tab", "benidipine hydrochloride uses.", "benidipine.", "benidipine 4 mg", "benidipine 4", "benidipine maximum dose", "benidipine 4 mg uses.", "benidipine price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }